{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:59:09Z","timestamp":1784138349168,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","award":["15-267"],"award-info":[{"award-number":["15-267"]}],"id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","award":["SDU2020"],"award-info":[{"award-number":["SDU2020"]}],"id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13195-019-0491-2","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T16:04:43Z","timestamp":1556726683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8747-7068","authenticated-orcid":false,"given":"Athanasios","family":"Metaxas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Anzalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanan","family":"Vaitheeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sussanne","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Finsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"issue":"9789","key":"491_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","volume":"378","author":"S Banerjee","year":"2011","unstructured":"Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403\u201311.","journal-title":"Lancet"},{"issue":"3","key":"491_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/da.22584","volume":"34","author":"J Moraros","year":"2017","unstructured":"Moraros J, Nwankwo C, Patten SB, Mousseau DD. The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: a systematic review and meta-analysis. Depress Anxiety. 2017;34(3):217\u201326.","journal-title":"Depress Anxiety"},{"issue":"3","key":"491_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","volume":"175","author":"C Bartels","year":"2018","unstructured":"Bartels C, Wagner M, Wolfsgruber S, Ehrenreich H, Schneider A. Alzheimer\u2019s disease neuroimaging I. Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer\u2019s dementia in individuals with previous depression. Am J Psychiatry. 2018;175(3):232\u201341.","journal-title":"Am J Psychiatry"},{"issue":"17","key":"491_CR4","doi-asserted-by":"crossref","first-page":"27676","DOI":"10.18632\/oncotarget.15398","volume":"8","author":"J Ma","year":"2017","unstructured":"Ma J, Gao Y, Jiang L, Chao FL, Huang W, Zhou CN, et al. Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe\/PSEN1dE9 double transgenic Alzheimer\u2019s disease mice. Oncotarget. 2017;8(17):27676\u201392.","journal-title":"Oncotarget"},{"issue":"1","key":"491_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.expneurol.2007.01.037","volume":"205","author":"RL Nelson","year":"2007","unstructured":"Nelson RL, Guo Z, Halagappa VM, Pearson M, Gray AJ, Matsuoka Y, et al. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp Neurol. 2007;205(1):166\u201376.","journal-title":"Exp Neurol"},{"key":"491_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.trci.2018.04.005","volume":"4","author":"M Severino","year":"2018","unstructured":"Severino M, Sivasaravanaparan M, Olesen LO, von Linstow CU, Metaxas A, Bouzinova EV, et al. Established amyloid-beta pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine. Alzheimers Dement (N Y). 2018;4:215\u201323.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"3","key":"491_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-151066","volume":"51","author":"AS Sierksma","year":"2016","unstructured":"Sierksma AS, de Nijs L, Hoogland G, Vanmierlo T, van Leeuwen FW, Rutten BP, et al. Fluoxetine treatment induces seizure behavior and premature death in APPswe\/PS1dE9 mice. J Alzheimers Dis. 2016;51(3):677\u201382.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"491_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1212\/WNL.0b013e3182a1ab4a","volume":"81","author":"EE Benarroch","year":"2013","unstructured":"Benarroch EE. Monoamine transporters: structure, regulation, and clinical implications. Neurology. 2013;81(8):761\u20138.","journal-title":"Neurology"},{"issue":"4","key":"491_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3233\/JAD-2010-100117","volume":"20","author":"P Holm","year":"2010","unstructured":"Holm P, Ettrup A, Klein AB, Santini MA, El-Sayed M, Elvang AB, et al. Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe\/PS1dE9 amyloid overexpressing mice. J Alzheimers Dis. 2010;20(4):1201\u201313.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"491_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","volume":"17","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001;17(6):157\u201365.","journal-title":"Biomol Eng"},{"key":"491_CR11","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1038\/cddis.2011.79","volume":"2","author":"HN Noristani","year":"2011","unstructured":"Noristani HN, Meadows RS, Olabarria M, Verkhratsky A, Rodriguez JJ. Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer\u2019s disease: an ultrastructural study. Cell Death Dis. 2011;2:e210.","journal-title":"Cell Death Dis"},{"issue":"1","key":"491_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1460-9568.2010.07274.x","volume":"32","author":"HN Noristani","year":"2010","unstructured":"Noristani HN, Olabarria M, Verkhratsky A, Rodriguez JJ. Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer\u2019s disease. Eur J Neurosci. 2010;32(1):71\u20139.","journal-title":"Eur J Neurosci"},{"key":"491_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuint.2017.04.008","volume":"108","author":"CU Von Linstow","year":"2017","unstructured":"Von Linstow CU, Severino M, Metaxas A, Waider J, Babcock AA, Lesch KP, et al. Effect of aging and Alzheimer\u2019s disease-like pathology on brain monoamines in mice. Neurochem Int. 2017;108:238\u201345.","journal-title":"Neurochem Int"},{"issue":"51","key":"491_CR14","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1523\/JNEUROSCI.4218-08.2008","volume":"28","author":"Y Liu","year":"2008","unstructured":"Liu Y, Yoo MJ, Savonenko A, Stirling W, Price DL, Borchelt DR, et al. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci. 2008;28(51):13805\u201314.","journal-title":"J Neurosci"},{"issue":"8","key":"491_CR15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","volume":"37","author":"L Trillo","year":"2013","unstructured":"Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, et al. Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. Translating basic science into clinical care. Neurosci Biobehav Rev. 2013;37(8):1363\u201379.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"491_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"3","key":"491_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbadis.2015.11.011","volume":"1862","author":"B Janssen","year":"2016","unstructured":"Janssen B, Vugts DJ, Funke U, Molenaar GT, Kruijer PS, van Berckel BN, et al. Imaging of neuroinflammation in Alzheimer\u2019s disease, multiple sclerosis and stroke: recent developments in positron emission tomography. Biochim Biophys Acta. 2016;1862(3):425\u201341.","journal-title":"Biochim Biophys Acta"},{"key":"491_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbi.2015.03.006","volume":"48","author":"AA Babcock","year":"2015","unstructured":"Babcock AA, Ilkjaer L, Clausen BH, Villadsen B, Dissing-Olesen L, Bendixen AT, et al. Cytokine-producing microglia have an altered beta-amyloid load in aged APP\/PS1 Tg mice. Brain Behav Immun. 2015;48:86\u2013101.","journal-title":"Brain Behav Immun"},{"issue":"33","key":"491_CR19","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci. 2008;28(33):8354\u201360.","journal-title":"J Neurosci"},{"issue":"10","key":"491_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry. 2010;68(10):930\u201341.","journal-title":"Biol Psychiatry"},{"issue":"13","key":"491_CR21","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/npp.2010.116","volume":"35","author":"CB Zhu","year":"2010","unstructured":"Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacol. 2010;35(13):2510\u201320.","journal-title":"Neuropsychopharmacol"},{"issue":"10","key":"491_CR22","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","volume":"31","author":"CB Zhu","year":"2006","unstructured":"Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacol. 2006;31(10):2121\u201331.","journal-title":"Neuropsychopharmacol"},{"key":"491_CR23","doi-asserted-by":"publisher","first-page":"9009","DOI":"10.1038\/srep09009","volume":"5","author":"E Kong","year":"2015","unstructured":"Kong E, Sucic S, Monje FJ, Savalli G, Diao W, Khan D, et al. STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior. Sci Rep. 2015;5:9009.","journal-title":"Sci Rep"},{"issue":"5","key":"491_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2174\/1567205014666171004113537","volume":"15","author":"A Metaxas","year":"2018","unstructured":"Metaxas A, Vaitheeswaran R, Jensen KT, Thygesen C, Ilkjaer L, Darvesh S, et al. Reduced serotonin transporter levels and inflammation in the midbrain raphe of 12 month old APPswe\/PSEN1dE9 mice. Curr Alzheimer Res. 2018;15(5):420\u20138.","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"491_CR25","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/jcbfm.2010.63","volume":"30","author":"DR Owen","year":"2010","unstructured":"Owen DR, Howell OW, Tang SP, Wells LA, Bennacef I, Bergstrom M, et al. Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab. 2010;30(9):1608\u201318.","journal-title":"J Cereb Blood Flow Metab"},{"key":"491_CR26","unstructured":"Allen Institute for Brain Science \u00a9 2004. Allen Mouse Brain Atlas. Available from: http:\/\/mouse.brain-map.org .\u00a0"},{"issue":"3","key":"491_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.22937","volume":"64","author":"M Grebing","year":"2016","unstructured":"Grebing M, Nielsen HH, Fenger CD, K TJ, von Linstow CU, Clausen BH, et al. Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration. Glia. 2016;64(3):407\u201324.","journal-title":"Glia"},{"key":"491_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainres.2008.03.060","volume":"1217","author":"EC Azmitia","year":"2008","unstructured":"Azmitia EC, Nixon R. Dystrophic serotonergic axons in neurodegenerative diseases. Brain Res. 2008;1217:185\u201394.","journal-title":"Brain Res"},{"issue":"2","key":"491_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ana.410220207","volume":"22","author":"RJ D'Amato","year":"1987","unstructured":"D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, et al. Aminergic systems in Alzheimer\u2019s disease and Parkinson\u2019s disease. Ann Neurol. 1987;22(2):229\u201336.","journal-title":"Ann Neurol"},{"issue":"3","key":"491_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2990.2006.00728.x","volume":"32","author":"AJ Thomas","year":"2006","unstructured":"Thomas AJ, Hendriksen M, Piggott M, Ferrier IN, Perry E, Ince P, et al. A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer\u2019s disease with and without depression. Neuropathol Appl Neurobiol. 2006;32(3):296\u2013303.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"491_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neurobiolaging.2010.03.023","volume":"33","author":"Lisbeth Marner","year":"2012","unstructured":"Marner L, Frokjaer VG, Kalbitzer J, Lehel S, Madsen K, Baare WF, et al. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer\u2019[s disease: a combined [11C] DASB and [18F]altanserin-PET study. Neurobiol Aging 2012;33(3):479\u2013487.","journal-title":"Neurobiology of Aging"},{"key":"491_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nbd.2017.05.007","volume":"105","author":"GS Smith","year":"2017","unstructured":"Smith GS, Barrett FS, Joo JH, Nassery N, Savonenko A, Sodums DJ, et al. Molecular imaging of serotonin degeneration in mild cognitive impairment. Neurobiol Dis. 2017;105:33\u201341.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"491_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1471-4159.1983.tb11838.x","volume":"41","author":"DM Bowen","year":"1983","unstructured":"Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, et al. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer\u2019s disease. J Neurochem. 1983;41(1):266\u201372.","journal-title":"J Neurochem"},{"issue":"1","key":"491_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1471-4159.1987.tb13120.x","volume":"48","author":"AM Palmer","year":"1987","unstructured":"Palmer AM, Francis PT, Benton JS, Sims NR, Mann DM, Neary D, et al. Presynaptic serotonergic dysfunction in patients with Alzheimer\u2019s disease. J Neurochem. 1987;48(1):8\u201315.","journal-title":"J Neurochem"},{"issue":"36","key":"491_CR35","doi-asserted-by":"publisher","first-page":"14968","DOI":"10.1073\/pnas.1107411108","volume":"108","author":"JR Cirrito","year":"2011","unstructured":"Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, et al. Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A. 2011;108(36):14968\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"236","key":"491_CR36","doi-asserted-by":"publisher","first-page":"236re4","DOI":"10.1126\/scitranslmed.3008169","volume":"6","author":"YI Sheline","year":"2014","unstructured":"Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, et al. An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci Transl Med. 2014;6(236):236re4.","journal-title":"Sci Transl Med"},{"issue":"268","key":"491_CR37","doi-asserted-by":"publisher","first-page":"268le5","DOI":"10.1126\/scitranslmed.3010053","volume":"6","author":"JF Emilsson","year":"2014","unstructured":"Emilsson JF, Andreasson U, Blennow K, Eriksson E, Zetterberg H. Comment on \u201cAn antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice\u201d. Sci Transl Med. 2014;6(268):268le5.","journal-title":"Sci Transl Med"},{"issue":"1","key":"491_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-017-0298-y","volume":"9","author":"CU von Linstow","year":"2017","unstructured":"von Linstow CU, Waider J, Grebing M, Metaxas A, Lesch KP, Finsen B. Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-beta levels in early-stage Alzheimer\u2019s-like disease in mice. Alzheimers Res Ther. 2017;9(1):74.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"491_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0304-3940(93)90216-8","volume":"163","author":"NC Inestrosa","year":"1993","unstructured":"Inestrosa NC, Alarcon R, Arriagada J, Donoso A, Alvarez J. Platelet of Alzheimer patients: increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine. Neurosci Lett. 1993;163(1):8\u201310.","journal-title":"Neurosci Lett"},{"issue":"3","key":"491_CR40","doi-asserted-by":"publisher","first-page":"B93","DOI":"10.1093\/geronj\/48.3.B93","volume":"48","author":"P Koren","year":"1993","unstructured":"Koren P, Diver-Haber A, Adunsky A, Rabinowitz M, Hershkowitz M. Uptake of serotonin into platelets of senile dementia of the Alzheimer type patients. J Gerontol. 1993;48(3):B93\u20136.","journal-title":"J Gerontol"},{"issue":"8","key":"491_CR41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1212\/WNL.41.8.1307","volume":"41","author":"RC Arora","year":"1991","unstructured":"Arora RC, Emery OB, Meltzer HY. Serotonin uptake in the blood platelets of Alzheimer\u2019s disease patients. Neurology. 1991;41(8):1307\u20139.","journal-title":"Neurology"},{"key":"491_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbi.2017.05.019","volume":"65","author":"MH Gronhoj","year":"2017","unstructured":"Gronhoj MH, Clausen BH, Fenger CD, Lambertsen KL, Finsen B. Beneficial potential of intravenously administered IL-6 in improving outcome after murine experimental stroke. Brain Behav Immun. 2017;65:296\u2013311.","journal-title":"Brain Behav Immun"},{"key":"491_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1742-2094-9-232","volume":"9","author":"A Kumar","year":"2012","unstructured":"Kumar A, Muzik O, Shandal V, Chugani D, Chakraborty P, Chugani HT. Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11) C-[R]-PK11195 PET. J Neuroinflammation. 2012;9:232.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"491_CR44","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013;16(12):1896\u2013905.","journal-title":"Nat Neurosci"},{"issue":"8","key":"491_CR45","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nn.4597","volume":"20","author":"TF Galatro","year":"2017","unstructured":"Galatro TF, Holtman IR, Lerario AM, Vainchtein ID, Brouwer N, Sola PR, et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat Neurosci. 2017;20(8):1162\u201371.","journal-title":"Nat Neurosci"},{"key":"491_CR46","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/brain\/aws113","volume":"135","author":"R Ossenkoppele","year":"2012","unstructured":"Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, et al. Amyloid burden and metabolic function in early-onset Alzheimer\u2019s disease: parietal lobe involvement. Brain. 2012;135(Pt 7:2115\u201325.","journal-title":"Brain"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0491-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0491-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0491-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T15:54:08Z","timestamp":1607529248000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0491-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0491-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Danish Animal Ethics Inspectorate (nr 2011\/561-1950) and complied with European Union directive 2010\/63\/EU, regulating animal research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"38"}}